 Preston Bratcher
Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystic Fibrosis Transmembrane Conductance Regulator | 14 | 2025 | 329 | 6.460 |
Why?
| | Aminophenols | 10 | 2025 | 156 | 3.660 |
Why?
| | Cystic Fibrosis | 16 | 2024 | 1114 | 3.240 |
Why?
| | Quinolones | 8 | 2025 | 137 | 3.030 |
Why?
| | Benzodioxoles | 7 | 2022 | 115 | 1.850 |
Why?
| | Indoles | 3 | 2022 | 412 | 1.270 |
Why?
| | Pulmonary Surfactant-Associated Protein D | 3 | 2014 | 35 | 1.260 |
Why?
| | Streptococcus pneumoniae | 4 | 2010 | 169 | 1.140 |
Why?
| | Epithelial Cells | 7 | 2025 | 1096 | 1.080 |
Why?
| | Chloride Channel Agonists | 3 | 2021 | 84 | 0.960 |
Why?
| | Pyrrolidines | 2 | 2022 | 79 | 0.890 |
Why?
| | Cyclic AMP | 1 | 2025 | 234 | 0.860 |
Why?
| | Neutrophils | 6 | 2019 | 1238 | 0.730 |
Why?
| | Bacterial Capsules | 3 | 2010 | 30 | 0.730 |
Why?
| | Pyrazoles | 2 | 2022 | 423 | 0.720 |
Why?
| | Pyridines | 2 | 2022 | 506 | 0.700 |
Why?
| | Epithelial Sodium Channels | 1 | 2021 | 20 | 0.700 |
Why?
| | Quinolines | 1 | 2021 | 178 | 0.670 |
Why?
| | Chlorides | 1 | 2020 | 136 | 0.640 |
Why?
| | Tetraspanin 30 | 2 | 2018 | 10 | 0.630 |
Why?
| | Receptors, Interleukin-8B | 1 | 2018 | 26 | 0.610 |
Why?
| | Pseudomonas | 1 | 2018 | 31 | 0.600 |
Why?
| | Klebsiella pneumoniae | 1 | 2018 | 47 | 0.590 |
Why?
| | Cells, Cultured | 8 | 2025 | 4193 | 0.560 |
Why?
| | Matrix Metalloproteinase 9 | 3 | 2022 | 132 | 0.550 |
Why?
| | Leukocytes | 1 | 2018 | 311 | 0.540 |
Why?
| | Epithelium | 3 | 2021 | 313 | 0.490 |
Why?
| | Drug Combinations | 3 | 2022 | 343 | 0.480 |
Why?
| | CD11b Antigen | 1 | 2015 | 61 | 0.460 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 565 | 0.460 |
Why?
| | Polypropylenes | 1 | 2013 | 13 | 0.420 |
Why?
| | 1-Methyl-3-isobutylxanthine | 2 | 2025 | 24 | 0.420 |
Why?
| | Colforsin | 2 | 2025 | 53 | 0.420 |
Why?
| | Serum Albumin, Bovine | 1 | 2013 | 64 | 0.410 |
Why?
| | Coated Materials, Biocompatible | 1 | 2013 | 62 | 0.400 |
Why?
| | Antibodies, Bacterial | 2 | 2010 | 146 | 0.390 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 852 | 0.380 |
Why?
| | Nasal Mucosa | 2 | 2024 | 107 | 0.380 |
Why?
| | Monocytes | 1 | 2015 | 563 | 0.380 |
Why?
| | Pneumococcal Infections | 2 | 2010 | 115 | 0.370 |
Why?
| | Aminopyridines | 3 | 2021 | 98 | 0.360 |
Why?
| | Biosynthetic Pathways | 1 | 2010 | 24 | 0.340 |
Why?
| | Serotyping | 4 | 2010 | 32 | 0.330 |
Why?
| | Bacteriological Techniques | 1 | 2010 | 73 | 0.330 |
Why?
| | Mutation | 6 | 2022 | 3958 | 0.320 |
Why?
| | Humans | 30 | 2025 | 137585 | 0.310 |
Why?
| | Immunity, Innate | 1 | 2012 | 828 | 0.250 |
Why?
| | Exosomes | 2 | 2019 | 103 | 0.250 |
Why?
| | Bronchi | 2 | 2019 | 260 | 0.250 |
Why?
| | Thyroid Epithelial Cells | 1 | 2025 | 1 | 0.230 |
Why?
| | Thiazolidines | 1 | 2025 | 9 | 0.230 |
Why?
| | Benzoates | 1 | 2025 | 43 | 0.230 |
Why?
| | Animals | 16 | 2025 | 36940 | 0.230 |
Why?
| | NIH 3T3 Cells | 2 | 2021 | 144 | 0.220 |
Why?
| | Ion Channel Gating | 1 | 2025 | 90 | 0.220 |
Why?
| | Rats, Inbred F344 | 1 | 2025 | 265 | 0.220 |
Why?
| | Genotype | 3 | 2021 | 1916 | 0.210 |
Why?
| | Mustard Gas | 1 | 2024 | 103 | 0.190 |
Why?
| | Chemical Warfare Agents | 1 | 2024 | 114 | 0.190 |
Why?
| | Proline | 2 | 2019 | 79 | 0.190 |
Why?
| | Dimethyl Sulfoxide | 1 | 2022 | 41 | 0.190 |
Why?
| | Respiratory System | 2 | 2022 | 157 | 0.180 |
Why?
| | Vaping | 1 | 2022 | 60 | 0.180 |
Why?
| | Electrophysiology | 1 | 2021 | 217 | 0.180 |
Why?
| | Rats | 3 | 2025 | 5647 | 0.170 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2900 | 0.170 |
Why?
| | Heterozygote | 1 | 2021 | 293 | 0.170 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2022 | 103 | 0.170 |
Why?
| | Ion Transport | 1 | 2020 | 60 | 0.170 |
Why?
| | Isocyanates | 1 | 2020 | 9 | 0.170 |
Why?
| | Forced Expiratory Volume | 2 | 2018 | 531 | 0.160 |
Why?
| | Drug Monitoring | 2 | 2018 | 218 | 0.160 |
Why?
| | Lipopolysaccharides | 3 | 2016 | 886 | 0.160 |
Why?
| | Respiratory Function Tests | 2 | 2018 | 600 | 0.160 |
Why?
| | Prodrugs | 1 | 2019 | 52 | 0.160 |
Why?
| | Sweat | 1 | 2018 | 47 | 0.150 |
Why?
| | Trachea | 1 | 2020 | 237 | 0.150 |
Why?
| | Down-Regulation | 1 | 2021 | 657 | 0.150 |
Why?
| | Homozygote | 1 | 2018 | 203 | 0.150 |
Why?
| | Biological Products | 1 | 2021 | 216 | 0.140 |
Why?
| | Tissue Plasminogen Activator | 1 | 2020 | 224 | 0.140 |
Why?
| | Airway Obstruction | 1 | 2020 | 162 | 0.140 |
Why?
| | Temperature | 1 | 2021 | 679 | 0.140 |
Why?
| | Adult | 7 | 2020 | 37929 | 0.140 |
Why?
| | Cilia | 1 | 2019 | 178 | 0.140 |
Why?
| | Respiratory Mucosa | 1 | 2020 | 321 | 0.140 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2017 | 26 | 0.140 |
Why?
| | ELAV-Like Protein 1 | 1 | 2017 | 16 | 0.130 |
Why?
| | Pseudomonas aeruginosa | 2 | 2016 | 352 | 0.130 |
Why?
| | Gene Deletion | 1 | 2018 | 391 | 0.130 |
Why?
| | Aztreonam | 1 | 2016 | 10 | 0.130 |
Why?
| | Mice | 6 | 2022 | 17787 | 0.130 |
Why?
| | Leukocyte Elastase | 2 | 2019 | 76 | 0.130 |
Why?
| | Sequence Analysis, DNA | 2 | 2010 | 812 | 0.130 |
Why?
| | Doxycycline | 1 | 2017 | 62 | 0.130 |
Why?
| | Lung | 5 | 2024 | 4060 | 0.130 |
Why?
| | Anti-Infective Agents | 1 | 2019 | 255 | 0.130 |
Why?
| | Tobramycin | 1 | 2016 | 52 | 0.130 |
Why?
| | Inflammation | 4 | 2022 | 2837 | 0.130 |
Why?
| | Pulmonary Emphysema | 1 | 2019 | 288 | 0.130 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 234 | 0.130 |
Why?
| | Male | 11 | 2022 | 67762 | 0.130 |
Why?
| | Escherichia coli | 2 | 2012 | 815 | 0.130 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2017 | 89 | 0.120 |
Why?
| | Transcriptome | 1 | 2022 | 971 | 0.120 |
Why?
| | Azithromycin | 1 | 2016 | 100 | 0.120 |
Why?
| | Serine Endopeptidases | 1 | 2016 | 123 | 0.120 |
Why?
| | Medication Adherence | 1 | 2018 | 467 | 0.110 |
Why?
| | Pseudomonas Infections | 1 | 2016 | 225 | 0.110 |
Why?
| | Microglia | 1 | 2017 | 251 | 0.110 |
Why?
| | Statistics as Topic | 1 | 2015 | 307 | 0.110 |
Why?
| | Cell Line | 3 | 2017 | 2847 | 0.110 |
Why?
| | Healthy Volunteers | 1 | 2014 | 199 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 1 | 2016 | 273 | 0.110 |
Why?
| | Mitochondrial Proteins | 1 | 2016 | 257 | 0.100 |
Why?
| | Logistic Models | 1 | 2018 | 2074 | 0.100 |
Why?
| | Adsorption | 1 | 2013 | 149 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1774 | 0.100 |
Why?
| | Reference Values | 1 | 2014 | 816 | 0.100 |
Why?
| | Genes, Bacterial | 2 | 2009 | 164 | 0.100 |
Why?
| | Smoking | 1 | 2020 | 1627 | 0.100 |
Why?
| | DNA, Bacterial | 2 | 2010 | 337 | 0.090 |
Why?
| | Proteolysis | 1 | 2012 | 177 | 0.090 |
Why?
| | Dinoprostone | 2 | 2022 | 191 | 0.090 |
Why?
| | Female | 8 | 2020 | 73304 | 0.090 |
Why?
| | Gene Order | 1 | 2010 | 26 | 0.090 |
Why?
| | Multilocus Sequence Typing | 1 | 2010 | 16 | 0.090 |
Why?
| | Cattle | 1 | 2013 | 984 | 0.090 |
Why?
| | Bacterial Typing Techniques | 1 | 2010 | 44 | 0.090 |
Why?
| | Gene Transfer, Horizontal | 1 | 2010 | 34 | 0.090 |
Why?
| | Phagocytosis | 1 | 2012 | 380 | 0.080 |
Why?
| | Cross Reactions | 1 | 2010 | 133 | 0.080 |
Why?
| | Matrix Metalloproteinases | 1 | 2011 | 95 | 0.080 |
Why?
| | Korea | 1 | 2009 | 16 | 0.080 |
Why?
| | Sequence Alignment | 1 | 2010 | 343 | 0.080 |
Why?
| | Recombination, Genetic | 1 | 2010 | 204 | 0.080 |
Why?
| | Macrophages, Alveolar | 1 | 2012 | 391 | 0.080 |
Why?
| | Genetic Loci | 1 | 2010 | 288 | 0.080 |
Why?
| | Cluster Analysis | 1 | 2010 | 499 | 0.080 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2009 | 58 | 0.070 |
Why?
| | Oligopeptides | 2 | 2019 | 271 | 0.070 |
Why?
| | Escherichia coli Proteins | 1 | 2009 | 200 | 0.070 |
Why?
| | Base Sequence | 1 | 2010 | 2181 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2018 | 10811 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2014 | 3284 | 0.060 |
Why?
| | Phylogeny | 1 | 2010 | 904 | 0.060 |
Why?
| | Evolution, Molecular | 1 | 2010 | 493 | 0.060 |
Why?
| | Sputum | 2 | 2019 | 311 | 0.060 |
Why?
| | Calcium | 1 | 2012 | 1199 | 0.060 |
Why?
| | Protein Binding | 1 | 2012 | 2224 | 0.060 |
Why?
| | Flow Cytometry | 1 | 2009 | 1178 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2010 | 1946 | 0.060 |
Why?
| | Mesna | 1 | 2024 | 16 | 0.050 |
Why?
| | Angiotensins | 1 | 2022 | 9 | 0.050 |
Why?
| | Mesocricetus | 1 | 2022 | 39 | 0.050 |
Why?
| | Sodium | 1 | 2024 | 217 | 0.050 |
Why?
| | Renin | 1 | 2022 | 35 | 0.050 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2022 | 56 | 0.050 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1430 | 0.050 |
Why?
| | Thromboplastin | 1 | 2022 | 74 | 0.050 |
Why?
| | Cotinine | 1 | 2022 | 77 | 0.050 |
Why?
| | Lubiprostone | 1 | 2022 | 9 | 0.050 |
Why?
| | Cricetinae | 1 | 2022 | 289 | 0.050 |
Why?
| | Receptors, Prostaglandin E, EP2 Subtype | 1 | 2022 | 6 | 0.050 |
Why?
| | Antidotes | 1 | 2024 | 143 | 0.050 |
Why?
| | Prostaglandins | 1 | 2022 | 97 | 0.050 |
Why?
| | DNA-Binding Proteins | 1 | 2009 | 1502 | 0.050 |
Why?
| | Interleukin-13 | 1 | 2022 | 149 | 0.040 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2019 | 1040 | 0.040 |
Why?
| | Superoxide Dismutase | 1 | 2022 | 346 | 0.040 |
Why?
| | Cyanates | 1 | 2019 | 4 | 0.040 |
Why?
| | Selenium Compounds | 1 | 2019 | 21 | 0.040 |
Why?
| | Thiocyanates | 1 | 2019 | 31 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 118 | 0.040 |
Why?
| | Nicotine | 1 | 2022 | 334 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 552 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2022 | 480 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 545 | 0.040 |
Why?
| | Smokers | 1 | 2020 | 145 | 0.040 |
Why?
| | Oscillometry | 1 | 2019 | 42 | 0.040 |
Why?
| | Chemotaxis | 1 | 2019 | 131 | 0.040 |
Why?
| | Smoke | 1 | 2019 | 141 | 0.040 |
Why?
| | Integrins | 1 | 2019 | 95 | 0.040 |
Why?
| | Video Recording | 1 | 2019 | 180 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4295 | 0.040 |
Why?
| | Anti-Bacterial Agents | 2 | 2019 | 1809 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2020 | 305 | 0.030 |
Why?
| | alpha 1-Antitrypsin | 1 | 2019 | 108 | 0.030 |
Why?
| | Microscopy | 1 | 2019 | 152 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 452 | 0.030 |
Why?
| | Matrix Metalloproteinase 12 | 1 | 2017 | 6 | 0.030 |
Why?
| | Alabama | 1 | 2017 | 33 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1242 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 313 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 5757 | 0.030 |
Why?
| | Drug Administration Routes | 1 | 2016 | 38 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1272 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2019 | 652 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 327 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 316 | 0.030 |
Why?
| | Young Adult | 3 | 2017 | 13209 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 2016 | 269 | 0.030 |
Why?
| | Signal Transduction | 2 | 2022 | 5079 | 0.030 |
Why?
| | Drug Interactions | 1 | 2016 | 410 | 0.030 |
Why?
| | Child, Preschool | 1 | 2009 | 11074 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2017 | 889 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2019 | 528 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 849 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2020 | 2486 | 0.030 |
Why?
| | Spinal Cord | 1 | 2017 | 370 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1570 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 469 | 0.030 |
Why?
| | Transfection | 1 | 2016 | 945 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2017 | 1993 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2057 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1704 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2757 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2011 | 19 | 0.020 |
Why?
| | Pancreatic Elastase | 1 | 2011 | 58 | 0.020 |
Why?
| | Airway Remodeling | 1 | 2011 | 64 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3196 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 2011 | 111 | 0.020 |
Why?
| | Chromosomes, Bacterial | 1 | 2009 | 7 | 0.020 |
Why?
| | Origin Recognition Complex | 1 | 2009 | 3 | 0.020 |
Why?
| | DNA Fragmentation | 1 | 2009 | 41 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2009 | 65 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2017 | 2833 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 3015 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3556 | 0.020 |
Why?
| | DNA Replication | 1 | 2009 | 238 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2009 | 328 | 0.020 |
Why?
| | Brain | 1 | 2017 | 2668 | 0.010 |
Why?
| | Chronic Disease | 1 | 2011 | 1793 | 0.010 |
Why?
| | Phosphorylation | 1 | 2009 | 1759 | 0.010 |
Why?
| | Models, Biological | 1 | 2011 | 1783 | 0.010 |
Why?
| | Macrophages | 1 | 2011 | 1547 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 21513 | 0.010 |
Why?
| | Aged | 1 | 2017 | 23961 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 33479 | 0.010 |
Why?
|
|
Bratcher's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|